ALCON

📅 Upcoming

🕒 Recent(90d)

News

• Alcon and OpenAI make acquisitions; Tezspire's latest Phase 3 win
  Alcon acquires Neurotech: The Swiss eye specialist paid $550 million upfront to acquire Neurotech Pharmaceuticals and could make additional payments if certain milestones are met. Alcon gains hold…
  endpoints · 12d ago
• Mid-cap biotechs join Trump’s latest round of drug pricing deals
  Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.
  biopharma_dive · 2mo ago
• STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more
  Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for a cancer drug. Read the latest pharma headlines in today's…
  stat · 2mo ago
• 9 midsize drugmakers climb aboard Trump’s MFN train
  Astellas Pharma, BridgeBio, BeOne Medicines and six other large biotechs join the 17 Big Pharmas that previously signed on to President Donald Trump’s Most Favored Nation (MFN) drug pricing program…
  biospace · 2mo ago
• STAT+: Trump strikes nine more deals with drugmakers to lower prices
  President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making such agreements.
  stat · 2mo ago
• STAT+: Up and down the ladder: The latest comings and goings
  From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
  stat · 6mo ago